TY - JOUR
T1 - Bupivacaine injection during midurethral sling and postoperative pain
T2 - A randomized controlled trial
AU - Dunivan, Gena C.
AU - Parnell, Brent A.
AU - Connolly, Anna Marie
AU - Jannelli, Mary L.
AU - Horton, Bethany Jablonski
AU - Geller, Elizabeth J.
N1 - Funding Information:
Acknowledgment This study was supported by award number 2KR20814 from the North Carolina Translational and Clinical Sciences Institute.
PY - 2011/4
Y1 - 2011/4
N2 - Introduction: and hypothesis The aim of this study was to investigate the impact of retropubic injection of 0.125% bupivacaine during midurethral sling placement on postoperative pain. Methods: A randomized, double-blind trial of 42 women undergoing midurethral sling for stress incontinence was conducted. The intervention group received an injection of 0.125% bupivacaine in the retropubic space prior to midurethral sling placement, while the control group received no injection. Pain scores were recorded via a 10-cm visual analog scale at 2, 6, and 24 h postoperatively. Results: Pain scores were lower in the bupivacaine group compared to the control group at 2 h (1.9 versus 2.6, p= 0.05). Mean pain scores were similar at all other time points (all p>0.45). Participants in both groups used similar amounts of pain medication in the hospital, except that patients in the bupivacaine group used more PO nonsteroidal anti-inflammatory drugs (p=0.047). Conclusions: Retropubic injection of 0.125% bupivacaine at the time of midurethral sling placement decreases shortterm postoperative pain.
AB - Introduction: and hypothesis The aim of this study was to investigate the impact of retropubic injection of 0.125% bupivacaine during midurethral sling placement on postoperative pain. Methods: A randomized, double-blind trial of 42 women undergoing midurethral sling for stress incontinence was conducted. The intervention group received an injection of 0.125% bupivacaine in the retropubic space prior to midurethral sling placement, while the control group received no injection. Pain scores were recorded via a 10-cm visual analog scale at 2, 6, and 24 h postoperatively. Results: Pain scores were lower in the bupivacaine group compared to the control group at 2 h (1.9 versus 2.6, p= 0.05). Mean pain scores were similar at all other time points (all p>0.45). Participants in both groups used similar amounts of pain medication in the hospital, except that patients in the bupivacaine group used more PO nonsteroidal anti-inflammatory drugs (p=0.047). Conclusions: Retropubic injection of 0.125% bupivacaine at the time of midurethral sling placement decreases shortterm postoperative pain.
KW - Bupivacaine
KW - Midurethral sling
KW - Postoperative pain
UR - http://www.scopus.com/inward/record.url?scp=79959782331&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79959782331&partnerID=8YFLogxK
U2 - 10.1007/s00192-011-1362-y
DO - 10.1007/s00192-011-1362-y
M3 - Article
C2 - 21318442
AN - SCOPUS:79959782331
SN - 0937-3462
VL - 22
SP - 433
EP - 438
JO - International Urogynecology Journal
JF - International Urogynecology Journal
IS - 4
ER -